Stock listing

HLBBF Stock Price, News, Filings & Events — H. Lundbeck A/s Class A

Selected listing: HLBBF · OTC · USD · US

This page tracks H. Lundbeck A/s Class A's HLBBF:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HLBBF:OTC. HLBBF:OTC is the stock-level entry point for investors researching H. Lundbeck A/s Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. H. Lundbeck A/s Class A is a public company based in Denmark, focusing on pharmaceuticals, particularly in the field of mental health. The company has a market capitalization of approximately 5.07 billion USD. Lundbeck is known for its commitment to developing innovative treatments for psychiatric and neurological disorders.

HLBBF:OTCUSDUSUpdated August 28, 2026
H. Lundbeck A/s Class A logo
Ticker
HLBBF:OTC
Asset type
Stock
Market cap
$5.17B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OTC
Currency
USD

H. Lundbeck A/s Class A HLBBF:OTC stock context

This page tracks H. Lundbeck A/s Class A's HLBBF:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HLBBF:OTC. HLBBF:OTC is the stock-level entry point for investors researching H. Lundbeck A/s Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. H. Lundbeck A/s Class A is a public company based in Denmark, focusing on pharmaceuticals, particularly in the field of mental health. The company has a market capitalization of approximately 5.07 billion USD. Lundbeck is known for its commitment to developing innovative treatments for psychiatric and neurological disorders.

Latest news from H. Lundbeck A/s Class A

All H. Lundbeck A/s Class A news →

H. Lundbeck A/s Class A earnings calls

Research H. Lundbeck A/s Class A

Alternate listings